A carregar...
Methotrexate inhibits the viability of human melanoma cell lines and enhances Fas/Fas-ligand expression, apoptosis and response to interferon-alpha: Rationale for its use in combination therapy
Melanoma, a highly aggressive form of cancer, is notoriously resistant to available therapies. Methotrexate (MTX), an antifolate, competitively inhibits DNA synthesis and is effective for several types of cancer. In cutaneous T-cell lymphoma (CTCL), MTX increases Fas death receptor by decreasing Fas...
Na minha lista:
Publicado no: | Arch Biochem Biophys |
---|---|
Main Authors: | , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4319533/ https://ncbi.nlm.nih.gov/pubmed/24862567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.abb.2014.04.019 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|